KILITCH DRUGS (INDIA)
Back to Cashflow Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹18 Cr | ₹-1.53 Cr | ₹2.59 Cr | ₹5.78 Cr | ₹46 Cr |
What is the latest Cash Flow from Operating Activities ratio of KILITCH DRUGS (INDIA) ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹-1.53 Cr |
| Mar2023 | ₹2.59 Cr |
| Mar2022 | ₹5.78 Cr |
| Mar2021 | ₹46 Cr |
How is Cash Flow from Operating Activities of KILITCH DRUGS (INDIA) Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | Positive | |
| Mar2024 | ₹-1.53 Cr | Negative | |
| Mar2023 | ₹2.59 Cr | -55.28 | |
| Mar2022 | ₹5.78 Cr | -87.33 | |
| Mar2021 | ₹46 Cr | - | |
Compare Cash Flow from Operating Activities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹661.5 Cr | -8.1% | 8.8% | -7.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -8.1% |
8.8% |
-7.1% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses